Trial site
Chu Dupuytren
- 15running trials
- 10closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer6 trials
- Lung cancer5 trials
- ALS (motor neurone disease)2 trials
- Gastric and oesophageal cancer2 trials
- Liver and biliary tract cancer2 trials
- Pancreatic cancer2 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- Brain metastases1 trial
- Cervical cancer1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- and 3 more
- Phase
- Phase 28 trials
- Phase 34 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Recruiting10 trials
- Completed9 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- UNICANCER3 trials
- Federation Francophone de Cancerologie Digestive2 trials
- Fondation Franc.Cancerologie Digestive2 trials
- 4TEEN4 Pharmaceuticals GmbH1 trial
- AB Science1 trial
- and 16 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Recruiting
Active, not recruiting
ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach
Recruiting
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Lung cancer3 recruiting
- Pancreatic cancer2 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Neuroendocrine tumours1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Not yet recruiting
Completed
Completed
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution
Completed
Completed
Completed
Completed
Completed
Completed
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026